DE69723258D1 - Thiadiazolyl(thio)harnstoffe und ihre verwendung als matrix-metallprotease inhibitoren - Google Patents
Thiadiazolyl(thio)harnstoffe und ihre verwendung als matrix-metallprotease inhibitorenInfo
- Publication number
- DE69723258D1 DE69723258D1 DE69723258T DE69723258T DE69723258D1 DE 69723258 D1 DE69723258 D1 DE 69723258D1 DE 69723258 T DE69723258 T DE 69723258T DE 69723258 T DE69723258 T DE 69723258T DE 69723258 D1 DE69723258 D1 DE 69723258D1
- Authority
- DE
- Germany
- Prior art keywords
- ulceration
- thiadiazolyl
- thio
- protease inhibitors
- matrix metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000011159 matrix material Substances 0.000 title abstract 2
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000002184 metal Substances 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- SSGGNFYQMRDXFH-UHFFFAOYSA-N sulfanylurea Chemical compound NC(=O)NS SSGGNFYQMRDXFH-UHFFFAOYSA-N 0.000 title 1
- 208000025865 Ulcer Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000036269 ulceration Effects 0.000 abstract 2
- 206010053555 Arthritis bacterial Diseases 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 208000004575 Infectious Arthritis Diseases 0.000 abstract 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 abstract 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 abstract 1
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 206010064996 Ulcerative keratitis Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000002808 connective tissue Anatomy 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 208000007565 gingivitis Diseases 0.000 abstract 1
- 230000009545 invasion Effects 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 201000001245 periodontitis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000001223 septic arthritis Diseases 0.000 abstract 1
- 108091007196 stromelysin Proteins 0.000 abstract 1
- 150000004867 thiadiazoles Chemical class 0.000 abstract 1
- 230000008354 tissue degradation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
- Glass Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1600396P | 1996-04-23 | 1996-04-23 | |
| PCT/US1997/005428 WO1997040031A1 (en) | 1996-04-23 | 1997-04-10 | Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69723258D1 true DE69723258D1 (de) | 2003-08-07 |
| DE69723258T2 DE69723258T2 (de) | 2004-01-29 |
Family
ID=21774823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69723258T Expired - Fee Related DE69723258T2 (de) | 1996-04-23 | 1997-04-10 | Thiadiazolyl(thio)harnstoffe und ihre verwendung als matrix-metallprotease inhibitoren |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0900211B1 (de) |
| JP (1) | JP2000509039A (de) |
| AT (1) | ATE244229T1 (de) |
| AU (1) | AU2603697A (de) |
| DE (1) | DE69723258T2 (de) |
| DK (1) | DK0900211T3 (de) |
| ES (1) | ES2202602T3 (de) |
| PT (1) | PT900211E (de) |
| WO (1) | WO1997040031A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997048688A1 (en) * | 1996-06-21 | 1997-12-24 | Pharmacia & Upjohn Company | Thiadiazole amide mmp inhibitors |
| KR20010112408A (ko) * | 1999-04-07 | 2001-12-20 | 모리타 다카카즈 | Ｎ-치환되고-Ｎ'-치환된 우레아 유도체 및 ＴＮＦ-α 생성억제제로서의 그의 용도 |
| DE19960640A1 (de) * | 1999-12-16 | 2001-06-28 | Aventis Pharma Gmbh | Neue Stromelysin Inhibitoren |
| ES2200617B1 (es) | 2001-01-19 | 2005-05-01 | Almirall Prodesfarma, S.A. | Derivados de urea como antagonistas de integrinas alfa 4. |
| US7115607B2 (en) | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
| JP4825375B2 (ja) * | 2001-08-28 | 2011-11-30 | 株式会社 資生堂 | ジチアゾール化合物及びマトリックスメタロプロテアーゼ活性阻害剤、皮膚外用剤 |
| PE20030701A1 (es) | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
| DE102006047153A1 (de) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren anti-entzündlichen Wirkstoffen |
| DE102006047164A1 (de) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren Hautbefeuchtungsmitteln |
| DE102006047160A1 (de) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit (R)-2-[((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-propionsäure-methylester und einem oder mehreren Füllstoffen |
| DE102006047155A1 (de) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninethylester und einem oder mehreren Antioxidantien |
| DE102006047157A1 (de) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren hautaufhellenden Wirkstoffen gegen unerwünschte Pigmentierung der Haut, insbesondere postinflammatorische Hyperpigmentierung |
| DE102006047163A1 (de) * | 2006-09-29 | 2008-04-03 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninmethylester und einem oder mehreren Antioxidantien |
| JP5580544B2 (ja) * | 2009-03-25 | 2014-08-27 | 国立大学法人群馬大学 | がん治療用の遊走阻害剤 |
| EP2511511B1 (de) | 2011-04-15 | 2016-05-11 | Caterpillar Motoren GmbH & Co. KG | Systemluftführungselement und Verbrennungsmotor mit einem Systemluftführungselement |
| EP2511510B1 (de) | 2011-04-15 | 2014-10-08 | Caterpillar Motoren GmbH & Co. KG | Motorblock und Verbrennungsmotor mit einem Motorblock |
| EP2527610B1 (de) | 2011-05-27 | 2015-03-18 | Caterpillar Motoren GmbH & Co. KG | SCR-Katalysator Sektion und ein Turbomotor damit |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62220954A (ja) * | 1986-03-20 | 1987-09-29 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
| US5239078A (en) * | 1990-11-21 | 1993-08-24 | Glycomed Incorporated | Matrix metalloprotease inhibitors |
| DK0740652T3 (da) * | 1994-01-20 | 1999-02-01 | British Biotech Pharm | Metalloproteinaseinhibitorer |
| US5677282A (en) * | 1995-06-07 | 1997-10-14 | Proscript, Inc. | Amino acid amides of 1,3,4-thiadiazoles as matrix metalloproteinase |
-
1997
- 1997-04-10 AT AT97917801T patent/ATE244229T1/de not_active IP Right Cessation
- 1997-04-10 DE DE69723258T patent/DE69723258T2/de not_active Expired - Fee Related
- 1997-04-10 DK DK97917801T patent/DK0900211T3/da active
- 1997-04-10 WO PCT/US1997/005428 patent/WO1997040031A1/en not_active Ceased
- 1997-04-10 PT PT97917801T patent/PT900211E/pt unknown
- 1997-04-10 ES ES97917801T patent/ES2202602T3/es not_active Expired - Lifetime
- 1997-04-10 JP JP9538079A patent/JP2000509039A/ja not_active Withdrawn
- 1997-04-10 EP EP97917801A patent/EP0900211B1/de not_active Expired - Lifetime
- 1997-04-10 AU AU26036/97A patent/AU2603697A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0900211B1 (de) | 2003-07-02 |
| AU2603697A (en) | 1997-11-12 |
| ATE244229T1 (de) | 2003-07-15 |
| WO1997040031A1 (en) | 1997-10-30 |
| DE69723258T2 (de) | 2004-01-29 |
| ES2202602T3 (es) | 2004-04-01 |
| PT900211E (pt) | 2003-10-31 |
| DK0900211T3 (da) | 2003-10-27 |
| EP0900211A1 (de) | 1999-03-10 |
| JP2000509039A (ja) | 2000-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY117762A (en) | Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation | |
| DE69723258T2 (de) | Thiadiazolyl(thio)harnstoffe und ihre verwendung als matrix-metallprotease inhibitoren | |
| TNSN02013A1 (fr) | Derives de benzothiadiazine, nouveaux inhibiteurs de metalloproteinases de matrice, et compositions les contenant | |
| YU40999A (sh) | N-hidroksi-2-(alkil,aril ili heteroaril sulfanil,sulfinil ili sulfonil)-3-supstituisani alkil,aril ili heteroarilamidi, kao inhibitori za matrične metaloproteinaze | |
| MX9804793A (es) | Acidos arilsulfonamido-hidroxamicos alfa-sustituidos como inhibidores de factor de necrosis tumoral-alfa y de metaloproteinasa de matriz. | |
| FI931888A0 (fi) | Kramploesande cykliska fruktopyranossulfiter -och sulfater | |
| WO1996040745A3 (en) | Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases | |
| YU54896A (sh) | (methilsulfonil)fenil-2-(5h)-furanoni kao cox-2 inhibitori | |
| GB8827305D0 (en) | Compounds | |
| MY136141A (en) | Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors | |
| MY122578A (en) | 2-oxy-benzoxazinone derivatives for the treatment of obesity | |
| NZ511885A (en) | 2,3,4,5-tetrahydro-1H-[1,4]benzodiazephine-3-hydroxamic acid as matrix metalloproteinase inhibitors and as inhibitors of TNF-alpha converting enzyme (TACE) | |
| ATE181055T1 (de) | Succinyl hydroxamsäure-, n-formyl-n-hydroxy- aminocarbonsäure- und succinsäureamid-derivate und ihre verwendung als metalloprotease- inhibitoren | |
| TR199902703T2 (xx) | Proteaz inhibit�rleri. | |
| WO2002053146A3 (en) | Matrix metalloproteinase inhibitors | |
| TR28332A (tr) | Arilasetik asit türevleri. | |
| TR200003252T2 (tr) | Interleukın-1ß dönüştürme enzimi succınamıde inhibitörleri. | |
| CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
| DE69719385D1 (de) | Mmp-hemmende thiadiazolylamide | |
| TW363056B (en) | Inhibition of matrix metalloproteases by substituted phenethyl compounds | |
| FR2775976B1 (fr) | Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase | |
| CA2244903A1 (en) | Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation | |
| DE60137023D1 (de) | 2-thio-4h-3,1-benzoxazin-4-on derivate und ihre verwendung als enzyminhibitoren | |
| MX9709955A (es) | Derivados del acido 5-pirazolilbenzoico. | |
| SU1623149A1 (ru) | Способ получения солей 2-имино-4-алкил(арил)тио-5,5-диалкил-2,5-дигидрофуранов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |